Preclinical evidence has shown increased expression of the OPRM1 gene in patients with CRC but there is no association with mortality or increased risk of reoccurrence24 and its role in cancer stage and genetic polymorphism has to be studied further. This evidence concerns the gene OPRM1 and colorectal carcinoma.